数据中心
龙虎榜
大单追踪
资金流向
业绩预告
新股申购
行情中心
沪深市场
香港市场
美国市场
全球市场
行业风云
全球市场
向上 向下

董事介绍

注:董事持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Yilin Wang Chairwoman and Chief Executive Officer 37 未披露 未持股 2023-07-14
Gerald T. Neal Independent director 72 未披露 未持股 2023-07-14
Zhe Liu Independent director 39 未披露 未持股 2023-07-14
Stephen P. Brown Independent director 64 未披露 未持股 2023-07-14
Wenjuan Liu Director 37 未披露 未持股 2023-07-14

高管介绍

注:高管持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Yilin Wang Chairwoman and Chief Executive Officer 37 未披露 未持股 2023-07-14
Rui Zhang Chief Financial Officer 40 未披露 未持股 2023-07-14

董事简历

中英对照 |  中文 |  英文
Yilin Wang

Yilin Wang自2016年3月起担任SOS Information Technology Co.,Ltd.(SOS Limited(NYSE:SOS)的全资子公司)的董事兼首席执行官,自2010年11月起担任Shijiazhuang Weigou Information Technology Co., Ltd.的创始人兼首席执行官。她是一名信息技术专家,在医疗卫生、健康管理和医疗技术相关业务方面拥有丰富的专业经验。她在中国河北科技大学获得管理学士学位,在中国河北地质大学获得科学和工程管理硕士学位。


Yilin Wang,has served as Akso Health Group Inc. chief executive officer since October 2021. From September 2021 to October 2021, Ms Wang served as the Co-CEO of the Company.She is an information technology expert and has rich professional experience in medical health, health management and medical technology-related businesses. Ms. Wang has served as the Director and CEO of SOS Information Technology Co., Ltd., a wholly-owned subsidiary of SOS Limited (NYSE: SOS) since March 2016, and has been the founder and CEO of Shijiazhuang Weigou Information Technology Co., Ltd., since November 2010. Ms. Wang obtained her bachelor's degree in management from the Hebei University of Science & Technology, China, and a master's degree in science and engineering management from the Hebei Dizhi University, China.
Yilin Wang自2016年3月起担任SOS Information Technology Co.,Ltd.(SOS Limited(NYSE:SOS)的全资子公司)的董事兼首席执行官,自2010年11月起担任Shijiazhuang Weigou Information Technology Co., Ltd.的创始人兼首席执行官。她是一名信息技术专家,在医疗卫生、健康管理和医疗技术相关业务方面拥有丰富的专业经验。她在中国河北科技大学获得管理学士学位,在中国河北地质大学获得科学和工程管理硕士学位。
Yilin Wang,has served as Akso Health Group Inc. chief executive officer since October 2021. From September 2021 to October 2021, Ms Wang served as the Co-CEO of the Company.She is an information technology expert and has rich professional experience in medical health, health management and medical technology-related businesses. Ms. Wang has served as the Director and CEO of SOS Information Technology Co., Ltd., a wholly-owned subsidiary of SOS Limited (NYSE: SOS) since March 2016, and has been the founder and CEO of Shijiazhuang Weigou Information Technology Co., Ltd., since November 2010. Ms. Wang obtained her bachelor's degree in management from the Hebei University of Science & Technology, China, and a master's degree in science and engineering management from the Hebei Dizhi University, China.
Gerald T. Neal

Gerald T. Neal,自2011年5月以来一直担任Baba commodities 总裁。2005年8月至2011年4月,他于1973年8月至2005年8月担任Guangyi Group Co., Ltd. 副总裁。Neal先生曾在E.I。杜邦公司股份有限公司担任多个职位,包括人事经理、安全与环境经理、运营经理和全球销售经理。Neal先生于1973年获得佐治亚大学学士学位。


Gerald T. Neal,has served as Akso Health Group Inc. independent director since June 7, 2022. Mr. Neal, has served as president of EightyEight Commodities Co since May 2011. From August 2005 to April 2011, he was vice president of Guangyi Group Inc. From August 1973 to August 2005, Mr. Neal served in various positions including personnel manager, safety & environmental manager, operations manager and worldwide sales manager at E.I. Dupont de Nemours Inc. Mr. Neal earned a Bachelor's degree from University of Georgia in 1973.
Gerald T. Neal,自2011年5月以来一直担任Baba commodities 总裁。2005年8月至2011年4月,他于1973年8月至2005年8月担任Guangyi Group Co., Ltd. 副总裁。Neal先生曾在E.I。杜邦公司股份有限公司担任多个职位,包括人事经理、安全与环境经理、运营经理和全球销售经理。Neal先生于1973年获得佐治亚大学学士学位。
Gerald T. Neal,has served as Akso Health Group Inc. independent director since June 7, 2022. Mr. Neal, has served as president of EightyEight Commodities Co since May 2011. From August 2005 to April 2011, he was vice president of Guangyi Group Inc. From August 1973 to August 2005, Mr. Neal served in various positions including personnel manager, safety & environmental manager, operations manager and worldwide sales manager at E.I. Dupont de Nemours Inc. Mr. Neal earned a Bachelor's degree from University of Georgia in 1973.
Zhe Liu

Zhe Liu于2012年创立了Shijiazhuang Zizhe Import and Export Trading Co., Ltd,自2012年1月起担任首席执行官。2011年6月至2012年1月任北Shijiazhuang Branch of Beijing Aohongxuan Wine Co., Ltd副经理。2009年8月至2011年6月份任Shijiazhuang Shengdian Pharmaceutical Co., Ltd河南区销售总监。Liu先生于2007年获得University of Portsmouth的营销和商务英语学士学位。


Zhe Liu,has served as Akso Health Group Inc. independent director since October 12, 2022. In 2012, Mr. Liu founded Shijiazhuang Zizhe Import and Export Trading Co., Ltd and served as CEO since January 2012. From June 2011 to January 2012, he served as deputy manager at Shijiazhuang Branch of Beijing Aohongxuan Wine Co., Ltd. From August 2009 to June 2011, he served as sales director at Henan Region of Shijiazhuang Shengdian Pharmaceutical Co., Ltd. Mr. Liu earned his bachelor's degree in marking and business English from University of Portsmouth in 2007.
Zhe Liu于2012年创立了Shijiazhuang Zizhe Import and Export Trading Co., Ltd,自2012年1月起担任首席执行官。2011年6月至2012年1月任北Shijiazhuang Branch of Beijing Aohongxuan Wine Co., Ltd副经理。2009年8月至2011年6月份任Shijiazhuang Shengdian Pharmaceutical Co., Ltd河南区销售总监。Liu先生于2007年获得University of Portsmouth的营销和商务英语学士学位。
Zhe Liu,has served as Akso Health Group Inc. independent director since October 12, 2022. In 2012, Mr. Liu founded Shijiazhuang Zizhe Import and Export Trading Co., Ltd and served as CEO since January 2012. From June 2011 to January 2012, he served as deputy manager at Shijiazhuang Branch of Beijing Aohongxuan Wine Co., Ltd. From August 2009 to June 2011, he served as sales director at Henan Region of Shijiazhuang Shengdian Pharmaceutical Co., Ltd. Mr. Liu earned his bachelor's degree in marking and business English from University of Portsmouth in 2007.
Stephen P. Brown

Stephen P. Brown于2013年9月从Bausch & Lomb Surgical离开加入STAAR,2008年至2013年他在Bausch & Lomb Surgical任全球财务部副总裁。在加入Bausch & Lomb之前,Brown先生曾是Hoya Surgical Optics的首席财务官,在Johnson & Johnson工作了13年,担任了许多职务,包括先进灭菌产品部门首席财务官。他的30年职业生涯也包括创立一家私营公司 Degree Baby Products,6年后该公司被卖给Johnson & Johnson。Brown先生获得了位于富尔顿的California State University的工商管理文学学士学位以及UCLA Anderson School of Management的工商管理硕士学位。


Stephen P. Brown,has served as Akso Health Group Inc. independent director since April 11, 2022. Mr. Brown, has served as the chief financial officer of SolarMax Technology, Inc. since May 2017. From 2013 until April 2017, he was chief financial officer of STAAR Surgical Company. Mr. Brown was vice president, global finance of Bausch & Lomb from 2008 until 2013 and chief financial officer of Hoya Surgical Optics from 2007 to 2008. He served in various capacities over a 13-year period with Johnson & Johnson including chief financial officer of the Advanced Sterilization Products division. Mr. Brown holds a Master of Business Administration degree from University of California, Los Angeles Anderson School of Management, and earned a Bachelor's degree from California State University, Fullerton.
Stephen P. Brown于2013年9月从Bausch & Lomb Surgical离开加入STAAR,2008年至2013年他在Bausch & Lomb Surgical任全球财务部副总裁。在加入Bausch & Lomb之前,Brown先生曾是Hoya Surgical Optics的首席财务官,在Johnson & Johnson工作了13年,担任了许多职务,包括先进灭菌产品部门首席财务官。他的30年职业生涯也包括创立一家私营公司 Degree Baby Products,6年后该公司被卖给Johnson & Johnson。Brown先生获得了位于富尔顿的California State University的工商管理文学学士学位以及UCLA Anderson School of Management的工商管理硕士学位。
Stephen P. Brown,has served as Akso Health Group Inc. independent director since April 11, 2022. Mr. Brown, has served as the chief financial officer of SolarMax Technology, Inc. since May 2017. From 2013 until April 2017, he was chief financial officer of STAAR Surgical Company. Mr. Brown was vice president, global finance of Bausch & Lomb from 2008 until 2013 and chief financial officer of Hoya Surgical Optics from 2007 to 2008. He served in various capacities over a 13-year period with Johnson & Johnson including chief financial officer of the Advanced Sterilization Products division. Mr. Brown holds a Master of Business Administration degree from University of California, Los Angeles Anderson School of Management, and earned a Bachelor's degree from California State University, Fullerton.
Wenjuan Liu

Wenjuan Liu自2018年8月起担任Hebei Chuangjie Technology Co., Ltd首席执行官。2015年5月至2018年7月,她担任Hebei Branch Key Client Manager of Guosen Co., Ltd.大客户经理。她于中国南开大学经济与管理系获得市场营销学士学位。


Wenjuan Liu,was appointed as Akso Health Group Inc. director on July 14, 2021. Ms. Liu has served as the Chief Executive Officer of Hebei Chuangjie Technology Co., Ltd. since August 2018. From May 2015 to July 2018, Ms. Liu served as the Key Client Manager of Hebei Branch of Guosen Co., Ltd. Ms. Liu has extensive experience in financial investments, capital market operations and enterprise management. Ms. Liu obtained her bachelor's degree in marketing from the Department of Economics and Management at Nankai University of China.
Wenjuan Liu自2018年8月起担任Hebei Chuangjie Technology Co., Ltd首席执行官。2015年5月至2018年7月,她担任Hebei Branch Key Client Manager of Guosen Co., Ltd.大客户经理。她于中国南开大学经济与管理系获得市场营销学士学位。
Wenjuan Liu,was appointed as Akso Health Group Inc. director on July 14, 2021. Ms. Liu has served as the Chief Executive Officer of Hebei Chuangjie Technology Co., Ltd. since August 2018. From May 2015 to July 2018, Ms. Liu served as the Key Client Manager of Hebei Branch of Guosen Co., Ltd. Ms. Liu has extensive experience in financial investments, capital market operations and enterprise management. Ms. Liu obtained her bachelor's degree in marketing from the Department of Economics and Management at Nankai University of China.

高管简历

中英对照 |  中文 |  英文
Yilin Wang

Yilin Wang自2016年3月起担任SOS Information Technology Co.,Ltd.(SOS Limited(NYSE:SOS)的全资子公司)的董事兼首席执行官,自2010年11月起担任Shijiazhuang Weigou Information Technology Co., Ltd.的创始人兼首席执行官。她是一名信息技术专家,在医疗卫生、健康管理和医疗技术相关业务方面拥有丰富的专业经验。她在中国河北科技大学获得管理学士学位,在中国河北地质大学获得科学和工程管理硕士学位。


Yilin Wang,has served as Akso Health Group Inc. chief executive officer since October 2021. From September 2021 to October 2021, Ms Wang served as the Co-CEO of the Company.She is an information technology expert and has rich professional experience in medical health, health management and medical technology-related businesses. Ms. Wang has served as the Director and CEO of SOS Information Technology Co., Ltd., a wholly-owned subsidiary of SOS Limited (NYSE: SOS) since March 2016, and has been the founder and CEO of Shijiazhuang Weigou Information Technology Co., Ltd., since November 2010. Ms. Wang obtained her bachelor's degree in management from the Hebei University of Science & Technology, China, and a master's degree in science and engineering management from the Hebei Dizhi University, China.
Yilin Wang自2016年3月起担任SOS Information Technology Co.,Ltd.(SOS Limited(NYSE:SOS)的全资子公司)的董事兼首席执行官,自2010年11月起担任Shijiazhuang Weigou Information Technology Co., Ltd.的创始人兼首席执行官。她是一名信息技术专家,在医疗卫生、健康管理和医疗技术相关业务方面拥有丰富的专业经验。她在中国河北科技大学获得管理学士学位,在中国河北地质大学获得科学和工程管理硕士学位。
Yilin Wang,has served as Akso Health Group Inc. chief executive officer since October 2021. From September 2021 to October 2021, Ms Wang served as the Co-CEO of the Company.She is an information technology expert and has rich professional experience in medical health, health management and medical technology-related businesses. Ms. Wang has served as the Director and CEO of SOS Information Technology Co., Ltd., a wholly-owned subsidiary of SOS Limited (NYSE: SOS) since March 2016, and has been the founder and CEO of Shijiazhuang Weigou Information Technology Co., Ltd., since November 2010. Ms. Wang obtained her bachelor's degree in management from the Hebei University of Science & Technology, China, and a master's degree in science and engineering management from the Hebei Dizhi University, China.
Rui Zhang

Rui Zhang自2019年8月起担任Akso Health Group Inc.首席财务官。张女士于2017年加入Akso Health Group Inc.,担任Akso Health Group Inc.的财务报告总监。2016年5月至2017年4月,张女士担任阿克康金融科技平台上海阿克普纳投资管理有限公司(Shanghai AkPurna Investment Management Co.,Ltd.)的战略发展总监和董事会秘书,负责制定和制定公司的长期战略、运营规划,为董事会提供持续的支持。从2011年4月至2016年5月,张女士在ReneSola Ltd.NYSE:SOL担任董事会秘书、项目投资经理、投资者关系经理和集团财务经理,协助创建和改进公司治理框架。张女士获得西北大学工商管理学士学位和悉尼大学专业会计硕士学位。


Rui Zhang,has served as Akso Health Group Inc. chief financial officer since August 2019. Ms. Zhang joined the Company in 2017 where she served as Akso Health Group Inc. financial reporting director. From May 2016 to April 2017, Ms. Zhang served as the strategy development director and board secretary for Shanghai AkPurna Investment Management Co., Ltd., Akcome's fintech platform, where she was responsible for formulating and developing the company's long-term strategy, operational planning, and providing ongoing support to the Board of Directors. From April 2011 to May 2016, Ms. Zhang served in various departmental roles including board secretary, project investment manager, investor relations manager, and group finance manager at ReneSola Ltd. (NYSE: SOL) where she helped create and improve their corporate governance framework. Ms. Zhang received a bachelor's degree in business administration from Northwest University for Nationalities and a master's degree in professional accounting from the University of Sydney.
Rui Zhang自2019年8月起担任Akso Health Group Inc.首席财务官。张女士于2017年加入Akso Health Group Inc.,担任Akso Health Group Inc.的财务报告总监。2016年5月至2017年4月,张女士担任阿克康金融科技平台上海阿克普纳投资管理有限公司(Shanghai AkPurna Investment Management Co.,Ltd.)的战略发展总监和董事会秘书,负责制定和制定公司的长期战略、运营规划,为董事会提供持续的支持。从2011年4月至2016年5月,张女士在ReneSola Ltd.NYSE:SOL担任董事会秘书、项目投资经理、投资者关系经理和集团财务经理,协助创建和改进公司治理框架。张女士获得西北大学工商管理学士学位和悉尼大学专业会计硕士学位。
Rui Zhang,has served as Akso Health Group Inc. chief financial officer since August 2019. Ms. Zhang joined the Company in 2017 where she served as Akso Health Group Inc. financial reporting director. From May 2016 to April 2017, Ms. Zhang served as the strategy development director and board secretary for Shanghai AkPurna Investment Management Co., Ltd., Akcome's fintech platform, where she was responsible for formulating and developing the company's long-term strategy, operational planning, and providing ongoing support to the Board of Directors. From April 2011 to May 2016, Ms. Zhang served in various departmental roles including board secretary, project investment manager, investor relations manager, and group finance manager at ReneSola Ltd. (NYSE: SOL) where she helped create and improve their corporate governance framework. Ms. Zhang received a bachelor's degree in business administration from Northwest University for Nationalities and a master's degree in professional accounting from the University of Sydney.